Mostrando 2 resultados de: 2
Filtros aplicados
Origen
scopus(2)
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics
ArticleAbstract: Aims Ongoing inflammation and endothelial dysfunction occurs within the local microenvironment of hePalabras claves:cardiomyopathy, Heart Failure, Nanoconstructs, Nanomedicine, Nanoparticles, nanotechnologyAutores:Amione-Guerra J., Andrea M. Cordero-Reyes, Blanco E., Cara F.E., Cruz-Solbes A.S., Ferrari M., Flores-Arredondo J.H., García-Rivas G., Guerrero-Beltrán C.E.n., Kirui D.K., Paez-Mayorga J., Ruiz-Esparza G.U., Segura-Ibarra V., Serda R.E., Torre-Amione G., Yokoi K., Youker K.A.Fuentes:scopusUse of stem cells in heart failure treatment: where we stand and where we are going
ReviewAbstract: End-stage heart failure is the final common pathway of an irreversible process associated with lossPalabras claves:bone marrow-derived cell therapy, cardiac stem cell therapy, dilated cardiomyopathy, Heart FailureAutores:Andrea M. Cordero-Reyes, García-Rivas G., Guerrero-Beltrán C.E.n., Sánchez L.A., Torre-Amione G.Fuentes:scopus